![](/img/cover-not-exists.png)
P057 PROSPER: A phase 3 study of enzalutamide in non-metastatic (M0) castration-resistant prostate cancer (CRPC) patients
Heidenreich, A., Sternberg, C., Fizazi, K., Saad, F., Shore, N.D., Hirmand, M., Perabo, F., Khondker, Z., Modelska, K., Hussain, M.Volume:
13
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(14)61280-X
Date:
November, 2014
File:
PDF, 63 KB
english, 2014